Gadoterate Meglumine 376.9 mg/mL
gadoterate meglumine · INJECTION · Fresenius Kabi USA, LLC
No Recall HistoryCurrently in Shortage
Plain English
Gadoterate Meglumine is a injection containing gadoterate meglumine at 376.9 mg/mL, taken intravenous. Manufactured by Fresenius Kabi USA, LLC.
Key Facts
- Brand Name
- Gadoterate Meglumine
- Generic Name
- gadoterate meglumine
- NDC Code (Product)
65219-086- Manufacturer
- Fresenius Kabi USA, LLC
- Strength
- 376.9 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA215304
- Marketing Start
- 06/20/2022
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
nausea20 reports
rash14 reports
dyspnoea13 reports
vomiting12 reports
oedema peripheral11 reports
pruritus11 reports
erythema10 reports
abdominal pain9 reports
drug reaction with eosinophilia and systemic symptoms9 reports
cough8 reports
Frequently Asked Questions
What is Gadoterate Meglumine used for?
Gadoterate Meglumine contains gadoterate meglumine. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Gadoterate Meglumine a controlled substance?
Gadoterate Meglumine is not classified as a controlled substance by the DEA.
What is the generic name for Gadoterate Meglumine?
The generic name for Gadoterate Meglumine is gadoterate meglumine. There are 5 other brand versions of gadoterate meglumine.
What is the NDC code for Gadoterate Meglumine 376.9 mg/mL?
The NDC (National Drug Code) for Gadoterate Meglumine 376.9 mg/mL is 65219-086, listed by Fresenius Kabi USA, LLC.